Early increase in marker of neuronal integrity with antidepressant treatment of major depression: 1H-magnetic resonance spectroscopy of N-acetyl-aspartate

Matthew J. Taylor, Beata R. Godlewska, Ray Norbury, Sudhakar Selvaraj, Jamie Near, Philip J. Cowen

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)
223 Downloads (Pure)

Abstract

Increasing interest surrounds potential neuroprotective or neurotrophic actions of antidepressants. While growing evidence points to important early clinical and neuropsychological effects of antidepressants, the time-course of any effect on neuronal integrity is unclear. This study used magnetic resonance spectroscopy to assess effects of short-term treatment with escitalopram on N-acetyl-aspartate (NAA), a marker of neuronal integrity. Thirty-nine participants with major depression were randomly assigned to receive either 10 mg escitalopram or placebo daily in a double-blind, parallel group design. On the seventh day of treatment, PRESS data were obtained from a 30x30x20 mm voxel placed in medial frontal cortex. Age and gender-matched healthy controls who received no treatment were also scanned. Levels of NAA were significantly higher in patients treated with escitalopram than in either placebo-treated patients (p < 0.01) or healthy controls (p < 0.01). Our findings are consistent with the proposition that antidepressant treatment in depressed patients can produce early changes in neuronal integrity.

Original languageEnglish
Pages (from-to)1541-1546
Number of pages6
JournalInternational Journal of Neuropsychopharmacology
Volume15
Issue number10
Early online date26 Mar 2012
DOIs
Publication statusPublished - Nov 2012

Fingerprint

Dive into the research topics of 'Early increase in marker of neuronal integrity with antidepressant treatment of major depression: 1H-magnetic resonance spectroscopy of N-acetyl-aspartate'. Together they form a unique fingerprint.

Cite this